- Home
- FMY vs JSPR Comparison
FMY vs JSPR Comparison
Compare FMY & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMY
- JSPR
- Stock Information
- Founded
- FMY 2005
- JSPR 2018
- Country
- FMY United States
- JSPR United States
- Employees
- FMY N/A
- JSPR N/A
- Industry
- FMY Finance/Investors Services
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FMY Finance
- JSPR Health Care
- Exchange
- FMY Nasdaq
- JSPR Nasdaq
- Market Cap
- FMY 50.5M
- JSPR 46.7M
- IPO Year
- FMY N/A
- JSPR N/A
- Fundamental
- Price
- FMY $12.15
- JSPR $3.11
- Analyst Decision
- FMY
- JSPR Buy
- Analyst Count
- FMY 0
- JSPR 12
- Target Price
- FMY N/A
- JSPR $30.78
- AVG Volume (30 Days)
- FMY 10.1K
- JSPR 311.4K
- Earning Date
- FMY 01-01-0001
- JSPR 08-13-2025
- Dividend Yield
- FMY 6.98%
- JSPR N/A
- EPS Growth
- FMY N/A
- JSPR N/A
- EPS
- FMY N/A
- JSPR N/A
- Revenue
- FMY N/A
- JSPR N/A
- Revenue This Year
- FMY N/A
- JSPR N/A
- Revenue Next Year
- FMY N/A
- JSPR N/A
- P/E Ratio
- FMY N/A
- JSPR N/A
- Revenue Growth
- FMY N/A
- JSPR N/A
- 52 Week Low
- FMY $10.71
- JSPR $2.27
- 52 Week High
- FMY $12.17
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- FMY 44.25
- JSPR 45.86
- Support Level
- FMY $12.17
- JSPR $2.81
- Resistance Level
- FMY $12.33
- JSPR $3.04
- Average True Range (ATR)
- FMY 0.06
- JSPR 0.21
- MACD
- FMY -0.02
- JSPR 0.10
- Stochastic Oscillator
- FMY 0.00
- JSPR 94.29
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.